Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Glendale
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Glendale, CA

Studies commonly pay $75 to $4,500 per completed study

2,957 clinical trials are currently recruiting participants within 30 miles of Glendale. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

2,957studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Glendale right now

Top 25 of 2,957 recruiting studies, sorted by proximity — each links to its official registry page

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (9.0 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
California Eye Specialists Medical group Inc. — Pasadena, California (6.3 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Solid Tumor, Non-Small-Cell Lung Cancer Phase 1 Interventional 364 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (17.9 mi) · Sponsor: Astellas Pharma Inc
See eligibility & contact on ClinicalTrials.gov (NCT07094204)

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Amyotrophic Lateral Sclerosis Phase 3 Interventional 495 participants sought
University of Southern California — Los Angeles, California (9.0 mi) · Sponsor: AB Science
See eligibility & contact on ClinicalTrials.gov (NCT03127267)

Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

Colorectal Cancer Metastatic Phase 2 Interventional 20 participants sought
USC/Norris Cancer Center — Los Angeles, California (9.0 mi) · Sponsor: Buzzard Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06634875)

Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

Renal Pelvis and Ureter Urothelial Carcinoma Phase 2 Interventional 21 participants sought
UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California (9.0 mi) · Sponsor: Jonsson Comprehensive Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT05775471)

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Solid Tumor Cancer, Locally Advanced Phase 1, Phase 2 Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Los Angeles, California (9.0 mi) · Sponsor: Avenzo Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07038343)

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL) Phase 1 Interventional 106 participants sought
City of Hope — Duarte, California (15.7 mi) · Sponsor: Umoja Biopharma
See eligibility & contact on ClinicalTrials.gov (NCT06528301)

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Renal Cell Carcinoma Phase 3 Interventional 904 participants sought
Providence Medical Foundation ( Site 0141) — Fullerton, California (28.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT07227402)

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Phase 1 Interventional 248 participants sought
City of Hope — Duarte, California (15.7 mi) · Sponsor: Nurix Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04830137)

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)

Angiokeratomas Phase 2 Interventional 15 participants sought
Unified Health — Sherman Oaks, California (11.8 mi) · Sponsor: Palvella Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07552077)

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Phase 1 Interventional 36 participants sought
City of Hope Medical Center — Duarte, California (15.7 mi) · Sponsor: PeproMene Bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05370430)

Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

Glioblastoma, Recurrent Glioblastoma N/A Interventional 50 participants sought
UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California (9.0 mi) · Sponsor: Jonsson Comprehensive Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT06090903)

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Systemic Lupus Erythematosus Phase 3 Interventional 550 participants sought
Providence Medical Center — Burbank, California (3.6 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06133972)

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

Viral Pneumonia Phase 2 Interventional 550 participants sought
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center — Torrance, California (24.5 mi) · Sponsor: Synairgen Research Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06999603)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought
Retension Clinical Site — West Hills, California (22.7 mi) · Sponsor: Retension Pharmaceuticals. Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07142356)

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
The Retina Partners — Encino, California (14.6 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Ulcerative Colitis, Crohn's Disease Phase 3 Interventional 240 participants sought
Cedars Sinai Medical Center - 127 San Vicente Blvd — Los Angeles, California (9.0 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT05442567)

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Atherosclerotic Cardiovascular Disease (ASCVD) Phase 3 Interventional 340 participants sought
National Heart Institute — Beverly Hills, California (11.5 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06813911)

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck Phase 1 Interventional 1,006 participants sought
Ronald Reagan UCLA Medical Center — Los Angeles, California (9.0 mi) · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT04389632)
Google-rated

Top-rated research centers in Glendale

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

California Clinical Trials

★ 3.4
1560 E Chevy Chase Dr, Glendale, CA 91206
(888) 228-7425
"The first time I went to this place for my screen for a health study the staff were nice at first but we I want back for my results of a couple days …"
— It’s Hillbillywillyyy, 3★

Lotus Clinical Research, LLC

★ 4.5
100 W California Blvd #25, Pasadena, CA 91105
(626) 568-8727
"It was to find because it's inside a hospital and they make you wait to get your research money where other research places pay you the same day"
— Gwendolyn Mitchelle, 5★

La Clinical Trials

★ 5.0
847 N Hollywood Way, Burbank, CA 91505
(818) 526-7645
"Eli is the bomb , never get stuck twice . He’s always on point . Thanks Eli and everybody working there ."
— Kevin Juengain, 5★

National Institute of Clinical Research

★ 3.0
600 S Lake Ave Ste 411, Pasadena, CA 91106
(323) 725-0657

Pasadena Clinical Trials

★ 3.0
65 N Madison Ave #701, Pasadena, CA 91101
(626) 822-6554
"I came in for a screening to see if I qualified for a clinical trial. The people who work there were friendly however after the screening they gave m…"
— Ashley Love, 1★

Bayview Research Group

★ 4.7
12626 Riverside Dr #404, Valley Village, CA 91607
(800) 831-8308
"Beautiful ❤️ office friendly staff"
— Rebecca Buehler, 5★

Los Angeles Clinical Trials

Burbank, CA 91505
(818) 526-7645

American Institute of Research

★ 4.5
1127 Wilshire Blvd Ste 1001, Los Angeles, CA 90017
(213) 699-4940
"The staff was kind and considerate... Although I didn't qualify for the study they still paid me anyway for showing up $50"
— Vanessa Taylor, 5★

Schuster Medical Research

★ 5.0
5000 Van Nuys Blvd #210, Sherman Oaks, CA 91403
(818) 788-0747
"Patient, they really listened and were very clear every step of the way. They wanted to make sure I understood. I really feel like they care about me…"
— ryan kemp, 5★

Clinical trials in Glendale: what's recruiting

The Glendale area currently has 2,957 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Glendale, the most active research areas are:

  • Cancer & Oncology12 studies
  • Heart & Vascular4 studies
  • Liver & Kidney3 studies
  • Immune & Skin2 studies

Every listing shows the study phase, the recruiting site and its distance from Glendale, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Glendale

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Glendale participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Glendale pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Glendale?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Glendale, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Glendale?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Glendale?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Glendale.

Paid clinical trials near Glendale

Other metros within reach

Los Angeles, CA2,943 Santa Clarita, CA2,395 Torrance, CA3,236 Long Beach, CA3,341 Palmdale, CA124 Fullerton, CA3,223 Garden Grove, CA3,152 Pomona, CA3,119

More of CA

Long Beach3,341 Torrance3,236 Fullerton3,223 Anaheim3,155 Garden Grove3,152 Pomona3,119 Los Angeles2,943 Huntington Beach2,841 Santa Clarita2,395 Hayward2,256 Oakland2,249

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts